Business Finland

Business Finland grant vs R&D loan: which one, when, and why the mix matters

Business Finland is often referred to as a single funding source, but it hands out two very different instruments: a **grant** (non-repayable) and an **R\&D loan** (repayable, low-interest, forgivable under conditions). Most sizeable R\&D projects use both, in a specific ratio, and the ratio isn't a detail — it materially changes what your project can afford to look like, and how much runway you carry after the money lands. Here is how the two work, when each fits, and the mistake most first-time applicants make about how to combine them.

Business Finland is often referred to as a single funding source, but it hands out two very different instruments: a grant (non-repayable) and an R&D loan (repayable, low-interest, forgivable under conditions). Most sizeable R&D projects use both, in a specific ratio, and the ratio isn’t a detail — it materially changes what your project can afford to look like, and how much runway you carry after the money lands.

Here is how the two work, when each fits, and the mistake most first-time applicants make about how to combine them.

The grant

What it is. A non-repayable award tied to eligible R&D costs. Business Finland typically covers a percentage of eligible costs (50% is the most common share for R&D projects at SMEs, though the share depends on the project category, the funding instrument, and the company’s size).

What it funds. Personnel, subcontracting, materials, indirect costs — every category listed in the eligible-cost rules. It cannot fund pure implementation, ordinary product work, or activities without genuine R&D uncertainty.

When it fits. Almost every credible R&D application uses grant funding as the primary layer. If your project has enough R&D novelty to qualify at all, the grant is the piece that carries the highest share.

The R&D loan

What it is. A low-interest loan that Business Finland extends alongside a grant on the same project, or as the primary instrument on larger projects. Interest is well below market. Under certain conditions — usually a failed R&D outcome or a specific technical uncertainty being resolved unfavourably — part of the loan can be converted to a grant, effectively forgiven.

What it funds. The same eligible-cost categories as the grant. In practice, the loan tops up the funding stack for projects that need more capital than the grant alone can carry.

When it fits. Larger R&D projects (often EUR 500,000+ in eligible costs) where the grant share alone is not enough to move the project, and the company can carry the repayment risk on the loan share. Also fits when the project’s downside — what happens if the R&D uncertainty doesn’t resolve — is well understood, because the loan’s forgivability makes that outcome less punishing.

The typical mix

For a mid-size R&D project — say EUR 300,000 in eligible costs — a common structure looks like this:

50% grant (EUR 150,000) covering the personnel and subcontracting share
20-30% R&D loan (EUR 60,000 – 90,000) topping up the same cost base
Remaining share funded by the company’s own contribution, in cash or eligible in-kind

The ratios move on project size, sector, company size, and how Business Finland’s evaluators grade the project. Larger projects lean more on loan; smaller projects lean more on grant.

The mistake most first-time applicants make

Treating the loan as an afterthought. Companies applying for the first time often anchor on the grant number and assume the loan is optional. It is optional — but declining the loan can leave the project underfunded in a way that Business Finland notices during evaluation, because the eligible-cost plan implies a certain total budget, and the company’s own contribution is expected to be realistic.

Read the loan as a lever, not a footnote:

Taking a larger loan share lets you present a more ambitious project without inflating the company’s own cash requirement
Taking a smaller loan share reduces post-approval repayment obligation, at the cost of a smaller total project
Declining the loan entirely is credible only when the grant alone is enough to fund the project you actually plan to run

Grant vs loan on the balance sheet

The two instruments show up differently on your books, and boards care about that:

Grant: other operating income, non-repayable, no debt line
R&D loan: long-term debt with a specific repayment schedule; forgivability provisions become relevant only if the R&D uncertainty resolves unfavourably

Companies raising equity in parallel need to think about this now, not later. A pure-grant structure is cleaner on the cap table conversation. A grant-plus-loan structure gives the R&D project more room to move but adds a debt line that a Series A investor will want explained.

The one-sentence version

The grant is the primary layer for almost every credible R&D application; the loan is the lever that decides how ambitious the project can afford to be — treat both as active choices, not defaults.